Skin Infection News and Research

RSS

Stronger version of chickenpox vaccine cuts incidence and severity of shingles in older adults

In one of the largest adult vaccine clinical trials ever, researchers have found that an experimental vaccine against shingles (zoster vaccine) prevented about half of cases of shingles--a painful nerve and skin infection--and dramatically reduced its severity and complications in vaccinated persons who got the disease. The findings appear in the June 2 issue of The New England Journal of Medicine.

1 Jun 2005

As science gets wiser, so do the bugs

As science gets wiser, so do the bugs. The rates of drug-resistant bacteria infecting patients in the community and in the hospital have been increasing steadily in recent years, according to two new studies in the June 15 issue of Clinical Infectious Diseases.

9 May 2005

Staph superbug now far more common in the community

Two teams of experts are saying that a drug-resistant "superbug" previously only found in hospitals is becoming more common in the community and must be aggressively treated. They say that staphylococcus aureus, or staph, infections that are resistant to methicillin and similar drugs can now be put into the category of flesh-eating bacteria and doctors need to be aware of this and exchange antibiotics at the first sign of trouble.

6 Apr 2005

Tumour Necrosis Factor alpha (TNF-alpha) blocking agents cause skin disease

Members of the second most important family of drugs used to treat rheumatoid arthritis can cause serious dermatological conditions in a quarter of patients under treatment, reveals a study published in the journal Arthritis Research and Therapy.

3 Apr 2005

Bacteria's rising threat studied

Infectious diseases researchers at Vanderbilt University Medical Center are noticing a significant increase in the number of infections due to Methicillin-Resistant Staphylococcus Aureus (MRSA), and the number of asymptomatic individuals who harbor the organism in their bodies.

29 Mar 2005

Drug-resistant bacteria MRSA a growing threat

Infectious diseases researchers at Vanderbilt University Medical Center are noticing a significant increase in the number of infections due to Methicillin-Resistant Staphylococcus Aureus (MRSA) and the number of asymptomatic individuals who harbor the organism in their bodies.

21 Mar 2005

Turf burns and body shaving responsible for the spread of a bacterial skin infection among football players

Turf burns and cosmetic body shaving were responsible for the spread of a bacterial skin infection among players on a college football team, according to an article in the November 15 issue of Clinical Infectious Diseases, now available online.

5 Nov 2004

Drug-resistant bacteria increasingly causing infections in healthy people

An emerging form of so-called "flesh-eating bacteria" is caused by a strain that is resistant to standard first-line antibiotics. The same type of bacteria, methicillin-resistant Staphylococcus aureus (MRSA) is causing record numbers of less-serious skin infections in children and also is emerging as a cause of pneumonia, which can be deadly

30 Sep 2004

We could soon be curing our athlete’s foot with alfalfa

We could be soon be curing our athlete’s foot with a common type of cattle feed, according to research reported today at the British Pharmaceutical Conference.

29 Sep 2004

Breast reconstruction at the time of mastectomy does not delay post-operative chemotherapy for women with breast cancer

“The findings weren’t a surprise to us, but we wanted to document the safety of immediate breast reconstruction so that surgeons in other settings can have the same confidence in the approach,” Bold said.

20 Sep 2004

Severe infections with flesh-eating bacteria are considerably more common than expected

In an EU project covering 11 countries, headed by Lund University in Sweden, it was calculated that some 1,000 cases would be found over an initial 1½-year period. Fully 5,000 were identified.

16 Sep 2004

Schering-Plough and Bayer form strategic alliance

Schering-Plough Corporation has announced that it has entered into a strategic agreement with Bayer designed to maximize the companies' pharmaceutical resources while maintaining each company's own strategic interests.

13 Sep 2004

Vaccine trial shows promising results for streptococcal infection protection

A study published in the current issue of JAMA reports that a streptococcal vaccine trial has shown promising results for protection against streptococcal infections.

11 Aug 2004

Research using genomic testing reveals new information on flesh-eating bacteria

New research using nearly a dozen different genomic testing procedures has revealed unprecedented detail about the molecular characteristics and virulence of group A streptococcus (GAS), the “flesh-eating” bacteria, according to scientists at the Rocky Mountain Laboratories, part of the National Institute of Allergy and Infectious Diseases.

27 Jul 2004